Stockreport

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]

iTeos Therapeutics, Inc.  (ITOS) 
PDF The early response was not positive, with shares down 7.8% to US$8.46 in the past week. This is an important time for investors, as they can track a company's performanc [Read more]